English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech HealthCare & Pharma
Mainetti to launch M-care PPE Range
May 27, 2020 06:00 HKT
Novotech and Endpoints to present APAC Clinical Trial webinar series
May 26, 2020 19:00 HKT
ZALL Group Donates 1 Million Surgical Masks to Singapore Red Cross (SRC)
May 23, 2020 11:00 HKT
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
May 20, 2020 18:15 HKT
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020
May 20, 2020 16:00 HKT
COVID-19 Crisis: Aetna Expands NIPT Coverage for Young Pregnant Women
May 19, 2020 03:00 HKT
Cyber Company to Supply 50M Health "COVI-PASS(TM)"
May 08, 2020 14:30 HKT
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
Apr 29, 2020 21:00 HKT
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 28, 2020 19:00 HKT
GeoMap Clinical Patient Recruitment Platform Now Guarantees Enrollment Numbers
Apr 28, 2020 15:00 HKT
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
Apr 27, 2020 09:50 HKT
Akeso, Inc. Enjoys Bright Prospects as Favored by the Capital Market
Apr 24, 2020 16:22 HKT
ZALL Foundation partners Alibaba to launch ebook on Fangcang Shelter Hospitals in the fight against COVID-19
Apr 30, 2020 18:00 HKT
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
Apr 24, 2020 10:00 HKT
Blockchain Holdings Enters into Definitive Agreement for Acquisition of COVID-19 Quarantine Management Product TRACEsafe
Apr 23, 2020 21:00 HKT
CStone announces acceptance of its first New Drug Application in mainland China by the National Medical Products Administration
Apr 23, 2020 13:45 HKT
Azabu Insights: Mask Usage in Tokyo Reaches Ninety-Seven Percent And Other Reasons Asian Countries Are Winning Against Coronavirus
Apr 23, 2020 23:00 HKT
TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical Trial
Apr 22, 2020 11:08 HKT
Shinsung TK Participates in 'Arab Health 2020', the Largest Medical Device Exhibition in the Middle East
Apr 24, 2020 16:00 HKT
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
Apr 21, 2020 06:30 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: